{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:47:26Z","timestamp":1792136846868,"version":"4.4.0"},"reference-count":39,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001084","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:31:33Z","timestamp":1069367493000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacotherapy for Behcet's syndrome"],"prefix":"10.1002","volume":"2010","author":[{"given":"Antonio","family":"Saenz","sequence":"first","affiliation":[{"name":"INSALUD - Madrid; Centro de Salud Pozuelo 1; Emisora s\/n Pozuelo de Alarc\u00f3n Madrid Spain 28224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ausejo","sequence":"additional","affiliation":[{"name":"Servicio de Farmacia Atencion Prinaria Area; 11 INSALUD, Benimamet 24-a Madrid Spain 28021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Shea","sequence":"additional","affiliation":[{"name":"University of Ottawa; Institute of Population Health; 1 Stewart St. Room 312 Ottawa Ontario Canada K1N 6N5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A","family":"Wells","sequence":"additional","affiliation":[{"name":"University of Ottawa Heart Institute; Cardiovascular Research Reference Centre; Room H1-1 40 Ruskin Street Ottawa Ontario Canada K1Y 4W7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Welch","sequence":"additional","affiliation":[{"name":"University of Ottawa; Centre for Global Health, Institute of Population Health; One Stewart Street, Room 206 Ottawa Ontario Canada K1N 6N5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tugwell","sequence":"additional","affiliation":[{"name":"University of Ottawa; Centre for Global Health, Institute of Population Health; One Stewart Street, Room 206 Ottawa Ontario Canada K1N 6N5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1998,4,27]]},"reference":[{"key":"10.1002\/14651858.CD001084-BIB0001|cit1","first-page":"399","article-title":"A double blind study of colchicine in behcet's disease","volume":"65","author":"Aktulga","year":"1980","journal-title":"Haematologica (Pavia)"},{"key":"10.1002\/14651858.CD001084-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0248-8663(05)80843-4","article-title":"Desensibilisation a la salive autologue et maladie de Behcet","volume":"12","author":"Benamour","year":"1991","journal-title":"Rev Med Interne"},{"issue":"3","key":"10.1002\/14651858.CD001084-BIB0003|cit3","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine A in Behcet's Syndrome","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD001084-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/art.1780391216","article-title":"The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with behcet's disease. A randomized clinical trial","volume":"39","author":"Calguneri","year":"1996","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD001084-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/rheumatology\/27.4.300","article-title":"Treatment with acyclovir does not affect orogenital ulcers in Behcet's syndrome: a randomized double-blind trial","volume":"27","author":"Davies","year":"1988","journal-title":"British Journal of Rheumatology"},{"key":"10.1002\/14651858.CD001084-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/rheumatology\/30.5.395-a","article-title":"Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behcet's syndrome: a randomized, double blind trial [letter]","volume":"30","author":"Hamuryudan","year":"1991","journal-title":"British Journal of Rheumatology"},{"key":"10.1002\/14651858.CD001084-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001084-BIB0008|cit8","first-page":"493","article-title":"Inefficacy of azapropazone in the acute arthritis of Behcet's syndrome: a randomized, double blind, placebo controlled study","volume":"13","author":"Moral","year":"1995","journal-title":"Clinical & Experimental Rheumatology"},{"key":"10.1002\/14651858.CD001084-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial","volume":"76","author":"Ozyazgan","year":"1992","journal-title":"British Journal of Ophtalmology"},{"key":"10.1002\/14651858.CD001084-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Behcet's syndrome","volume":"322","author":"Yacizi","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001084-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/bjo.57.9.706","article-title":"Long-lasting remission of Behcet's disease after chlorambucil therapy","volume":"57","author":"Abdalla","year":"1973","journal-title":"Br-J-Ophtalmol"},{"key":"10.1002\/14651858.CD001084-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0002-9394(14)71081-5","article-title":"Tolerance and uveitis. Editorial","volume":"123","author":"Bach","year":"1997","journal-title":"Am J Ophtalmol"},{"key":"10.1002\/14651858.CD001084-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00161239","article-title":"Cyclosporine effects on optic nerve and retinal vasculitis in Behcet's disease","volume":"80","author":"Chavis","year":"1992","journal-title":"Documenta Ophthalmologica"},{"key":"10.1002\/14651858.CD001084-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/000348949110000607","article-title":"Effect of cyclosporine A on the hearing loss in Behcet's disease","volume":"100","author":"Elidan","year":"1991","journal-title":"Annals of Otology, Rhinology & Laryngology"},{"key":"10.1002\/14651858.CD001084-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.53.12.828","article-title":"Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy","volume":"53","author":"Gardner-Medwin","year":"1994","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD001084-BIB0016|cit16","first-page":"51","article-title":"Topical alpha interpheron in the treatment of oral ulcers in Behcet's syndrome: a preliminary report","volume":"8","author":"Hamuryudan","year":"1990","journal-title":"Clinical & Experimental Rheumatology"},{"key":"10.1002\/14651858.CD001084-BIB0017|cit17","first-page":"1098","article-title":"Systemic Interpheron alpha 2b treatment in Behect's syndrome","volume":"21","author":"Hamuryudan","year":"1994","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD001084-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Behcet's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD001084-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02229648","article-title":"The frequency and clinical characterisitcs of methotrxate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study","volume":"15","author":"Ince","year":"1996","journal-title":"Clinical Rheumatology"},{"key":"10.1002\/14651858.CD001084-BIB0020|cit20","first-page":"148","article-title":"Long-term effects of cyclophosphamide and colchicine treatment in behcet's disease","volume":"23","author":"Kazokoglu","year":"1991","journal-title":"Ann Ophtalmol"},{"key":"10.1002\/14651858.CD001084-BIB0021|cit21","first-page":"3343","article-title":"A multicenter clinical open trial of FK506 in refractory uveitis, including Behcet's disease. Japanese FK 506 Study Group on refractory Uveitis","volume":"23","author":"Mochizuki","year":"1991","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD001084-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9394(14)77814-6","article-title":"Cyclosporine Therapy in the treatment of intraocular inflammatory disease resistant to systemic steroids and cytotoxic agents","volume":"96","author":"Nussenblatt","year":"1983","journal-title":"Am J Ophtalmol"},{"key":"10.1002\/14651858.CD001084-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(83)90230-1","article-title":"Treatment of intraocular inflammatory disease with cyclosporine A","volume":"ii","author":"Nussenblatt","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001084-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780280611","article-title":"Effectiveness of cyclosporin therapy for Behcet's disease","volume":"28","author":"Nussenblatt","year":"1985","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD001084-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/jop.1985.1.369","article-title":"Cyclosporine therapy for uveitis: long-term follow-up","volume":"1","author":"Nussenblatt","year":"1985","journal-title":"Journal of Ocular Pharmacology"},{"key":"10.1002\/14651858.CD001084-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1749-6632.1996.tb21140.x","article-title":"Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report. [Review]","volume":"778","author":"Nussenblatt","year":"1996","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD001084-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0002-9394(14)71070-0","article-title":"Treatment of uveitis by oral administration of retinal antigens: results of a phase I\/II randomized masked trial","volume":"123","author":"Nussenblatt","year":"1997","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD001084-BIB0028|cit28","first-page":"802","article-title":"[A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behcet's disease and allied conditions]","volume":"35","author":"Sakane","year":"1995","journal-title":"Ryumachi"},{"key":"10.1002\/14651858.CD001084-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-4362.1991.tb05883.x","article-title":"Treatment of Behcet's disease with indomethacin","volume":"30","author":"Simsek","year":"1991","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD001084-BIB0030|cit30","first-page":"262","article-title":"Traitement Medical de la Maladie de Behcet","volume":"13","author":"Wechsler","year":"1988","journal-title":"Journal des Maladies Vasculaires (Paris)"},{"key":"10.1002\/14651858.CD001084-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","article-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease","volume":"118","author":"Whitcup","year":"1994","journal-title":"American Journal of Ophtalmology"},{"key":"10.1002\/14651858.CD001084-BIB0032|cit32","first-page":"125","article-title":"Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet's disease","volume":"192","author":"Calguneri","year":"1996","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD001084-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-124-5-199603010-00004","article-title":"The quality of drug studies published in symposium proceedings","volume":"124","author":"Cho","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001084-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001084-BIB0035|cit35","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. [Review] [16 refs]","volume":"335","author":"Anonymous","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001084-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001084-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD001084-BIB0038|cit38","article-title":"Chapter 2.90: Behcet's Syndrome","volume-title":"Harrison's Principles of Internal Medicine","author":"Moutsopoulos","year":"1994"},{"key":"10.1002\/14651858.CD001084-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:02:42Z","timestamp":1792134162000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001084"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[1998,4,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001084","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4,27]]}}}